Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 09 - 07 tags : Drug save search
Diabetic Nephropathy Market to Gain from Increasing Patient Burden and New Drug Launches; Growing at a 6.5% CAGR During the Study Period [2018-2030], Evaluates DelveInsight
Published: 2021-09-07 (Crawled : 18:00) - prnewswire.com
LLY | News | $731.33 0.69% 0.36% 1.7M
|
Health Technology
|
| O: -0.41%
H: 0.7%
C: -1.62%
new drug nephropathy growing drug diabetic diabetes
U.S. FDA Accepts for Priority Review Supplemental New Drug Application for Oxbryta® (voxelotor) for the Treatment of Sickle Cell Disease in Children Ages 4 to 11
Published: 2021-09-07 (Crawled : 13:15) - biospace.com/
GBT | $68.49 0.02% -0.02%
|
Health Technology
|
| O: 1.23%
H: 1.51%
C: -2.39%
new drug disease treatment fda oxbryta children drug fda acceptance
Anticoagulant Reversal Drugs Market Size Is Projected to Reach $2.20 Billion By 2028 | CAGR: 14.4%: Polaris Market Research
Published: 2021-09-07 (Crawled : 13:00) - prnewswire.com
PFE | News A | $26.26 1.0% 0.38% 29M
|
Health Technology
|
| O: 0.23%
H: 1.09%
C: -0.51%
BHC | $8.45 -2.76% -0.24% 2.1M
|
Health Technology
|
| O: -0.72%
H: 1.0%
C: 0.45%
drug research
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
DPRO | News | $0.28 16.91% 16.26% 24K
|
CANG | $1.34 -4.29% 14.93% 120K
|
Technology Services
AZTR 4 | $0.195 13.85% 42K
|
n/a
TOVX | News | $0.411 -1.01% 12.9% 230K
|
Manufacturing
CISS | $1.3 11.11% 10.0% 42K
|
n/a
SQNS | $0.504 -9.19% 9.25% 110K
|
Electronic Technology
CR | $130.73 0.97% 8.82% 230K
|
Producer Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.